HCA Healthcare (NYSE:HCA) Price Target Lowered to $475.00 at Mizuho

HCA Healthcare (NYSE:HCA) had its price target cut by analysts at Mizuho from $525.00 to $475.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Mizuho’s price target points to a potential upside of 21.88% from the company’s previous close.

Other equities analysts also recently issued reports about the company. TD Cowen dropped their target price on HCA Healthcare from $500.00 to $431.00 and set a “buy” rating for the company in a research report on Monday, June 22nd. Wall Street Zen downgraded HCA Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. Jefferies Financial Group set a $450.00 price target on shares of HCA Healthcare in a research report on Tuesday, July 14th. Barclays cut their price target on HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating on the stock in a report on Monday. Finally, Stephens cut their target price on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating on the stock in a report on Monday, April 27th. Fourteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and an average target price of $468.36.

HCA Healthcare Stock Performance

HCA Healthcare stock opened at $389.74 on Tuesday. The stock has a market capitalization of $86.46 billion, a P/E ratio of 13.05, a price-to-earnings-growth ratio of 1.29 and a beta of 1.12. HCA Healthcare has a 52 week low of $331.61 and a 52 week high of $556.52. The stock has a fifty day moving average of $386.30 and a 200-day moving average of $452.90.

HCA Healthcare (NYSE:HCA) last issued its earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The firm had revenue of $20.23 billion for the quarter, compared to analyst estimates of $19.76 billion. During the same quarter last year, the business posted $6.84 earnings per share. The company’s quarterly revenue was up 8.7% on a year-over-year basis. On average, research analysts forecast that HCA Healthcare will post 29.19 earnings per share for the current year.

Institutional Trading of HCA Healthcare

A number of large investors have recently bought and sold shares of HCA. Norges Bank bought a new position in shares of HCA Healthcare during the 4th quarter worth $1,262,513,000. Life Cycle Investment Partners Ltd purchased a new position in shares of HCA Healthcare in the fourth quarter worth about $374,037,000. Viking Global Investors LP boosted its holdings in HCA Healthcare by 58.5% in the 2nd quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after buying an additional 690,773 shares during the period. Northwestern Mutual Wealth Management Co. boosted its holdings in shares of HCA Healthcare by 4,545.5% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 663,337 shares of the company’s stock worth $309,686,000 after acquiring an additional 649,058 shares during the period. Finally, Healthcare of Ontario Pension Plan Trust Fund lifted its holdings in HCA Healthcare by 5,941.1% during the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 381,433 shares of the company’s stock worth $180,509,000 after purchasing an additional 375,119 shares in the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

Key HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA reported second-quarter earnings of $7.59 per share, narrowly exceeding the $7.56 consensus estimate. Revenue rose 8.7% year over year to $20.23 billion, also ahead of the $19.76 billion forecast, supporting the stock’s recent strength. HCA Healthcare’s Q2 CY2026 sales top estimates
• Positive Sentiment: Several analysts retained bullish ratings despite lowering their targets after the earnings release. Truist cut its target to $495 from $535 while maintaining “buy,” and Oppenheimer reduced its target to $485 from $520 while keeping an “outperform” rating. HCA Healthcare analysts slash their forecasts after Q2 results
• Positive Sentiment: HCA declared a quarterly dividend of $0.78 per share, payable September 30 to shareholders of record September 16, providing continued shareholder income. The indicated yield is approximately 0.8%.
• Neutral Sentiment: HCA appointed Jordan Fulkerson as chief financial officer of HCA Florida Memorial Hospital and promoted new chief executives at two Tampa hospitals. The moves may strengthen local operations but are unlikely to materially affect near-term valuation. Jordan Fulkerson named CFO of HCA Florida Memorial Hospital HCA promotes new CEO of two Tampa hospitals
• Negative Sentiment: Analysts broadly lowered price targets following the results: KeyCorp cut its target to $435, RBC reaffirmed “outperform” with a $435 target, and Baird reduced its target to $393 with a “neutral” rating. Barclays lowered its target to $387 and maintained “equal weight,” signaling limited near-term upside.
• Negative Sentiment: Almost all of HCA’s Affordable Care Act exchange patients are reportedly becoming uninsured, creating concern about uncompensated care, payer mix and earnings durability despite the quarterly beat. Almost all of HCA’s Affordable Care Act patients are going uninsured

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.